Teen who had heart attack after vaccine dose to receive $225,000
Updated: Sep 6
This is an interesting development.
Thousands of Americans have suffered myocarditis after receiving the emergency use authorized Pfizer/BioNTech vaccine. In fact, heart inflammation is now widely-acknowledged as a known risk to teens and young adults following vaccination.
Yet not one of these people has received a dime for their injuries.
By contrast, a Taiwanese boy who suffered the same injury — after receiving Pfizer's FDA-approved Comirnaty vaccine — was recently compensated with a whopping $225,000.
Now, ask yourself: if your employer was forcing you to get jabbed, which vaccine would YOU want?
I think we all know the answer. Unfortunately, if you're an American, you don't have a choice; Comirnaty isn't even available in the United States. Probably just a coincidence.
"SINGAPORE — The 16-year-old teenager who suffered a heart attack six days after receiving his first dose of the Pfizer-BioNTech/Comirnaty COVID-19 vaccine will be eligible for a one-time financial assistance of $225,000.
This will be provided under Singapore's Vaccine Injury Financial Assistance Programme (VIFAP), said the Ministry of Health (MOH) on Monday (16 August) in a press statement.
It added that medical investigations have found that the youth had developed acute severe myocarditis which led to the out-of-hospital cardiac arrest.
"The myocarditis was likely a serious adverse event arising from the COVID-19 vaccine he received, which might have been aggravated by his strenuous lifting of weights and his high consumption of caffeine through energy drinks and supplements," it said.
The teenager is currently "recovering steadily" and undergoing inpatient rehabilitation, the MOH added.
"He is making good progress and can perform his activities of daily living without assistance," it noted adding that the teenager will likely be discharged in the coming weeks. However, he will also likely require outpatient rehabilitation for some time before he can return to school and resume other activities.
The medical team will continue his treatment and monitor his condition, said the MOH.
"The independent clinical panel appointed to assess and adjudicate the VIFAP application found that while he has made good improvement, because his condition was severe and critical, he will require treatment and rehabilitation for some time yet to continue his recovery," added the ministry."
I'm always interested in knowing if my content resonates with readers. If you enjoyed this article, please click the "love" button. Comments are also appreciated!